GSK2983559 First Time in Human Study

NCT03358407 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to non clinical toxicology findings and reduced safety margins.

Conditions

Inflammatory Bowel Diseases

Interventions

DRUG: GSK2983559
DRUG: Placebo

Sponsor

GlaxoSmithKline